US
SafeHeal® is proud to announce its inclusion in Life Science Intelligence’s (LSI) Q1 Hot 25 MedTech Startups list. ...
SafeHeal® Announces Successful Launch of SAFE-3CV IDE Study for Colovac® Anastomosis Protection Technology
SafeHeal announced the first patient enrollment in its pivotal IDE study of Colovac, a groundbreaking endoluminal bypass sheath....
SafeHeal’s Jenny Gaffney to Address Medicare Reimbursement at The MedTech Conference 2025
Jenny Gaffney, SafeHeal's VP of Healthcare Economics & Reimbursement, will address Medicare reimbursement at The MedTech Conference 2025....
SafeHeal® Receives European Marketing Approval Under MDR for Colovac® Anastomosis Protection Technology
SafeHeal announced that it has been granted European Union marketing approval for its Colovac device under the new Medical Device Regulation (EU MDR 2...
SafeHeal® Closes Oversubscribed €35 Million Series C Equity Financing
Breakthrough device promises significantly improved patient recovery after colorectal surgery....
SafeHeal Receives Breakthrough Device designation for Colovac Endoluminal Bypass Sheath
Breakthrough device promises significantly improved patient recovery after colorectal surgery....
Chief Executive Officer Chris Richardson to Speak at LSI Emerging Medtech Summit
Chris Richardson, CEO of SafeHeal, will be presenting an overview of the benefits of Colovac to strategic partners....
SafeHeal appoints medical device industry veteran Chris Richardson as Chief Executive Officer
Breakthrough device promises significantly improved patient recovery after colorectal surgery....